Elevate1 trial to assess safety and tolerability of study drug in patients with pulmonary arterial hypertension
The purpose of this study is to assess the safety, tolerability and drug levels of RVT-1201 when given for six weeks to patients with Pulmonary Hypertension.
This research study is led by Dr. Mary Jo Farmer.
Contact: Sarah Romain, 413-794-4889
August 01, 2019
Pulmonary/ Critical Care
Baystate Medical Center, 759 Chestnut Street, Springfield, MA
- Pulmonary Hypertension
- Age 18-75